EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
14 hedge funds and large institutions have $288K invested in EnteroMedics Inc. in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
13% less funds holding
Funds holding: 16 → 14 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
55% less capital invested
Capital invested by funds: $646K → $288K (-$358K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$54.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$48.4K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.36K |
| 5 |
Morgan Stanley
New York
|
+$1.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$66K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$10.6K |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
-$7K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$5K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$2K |
ETRM Hedge Fund Activity: Q3 2017 in Review
14 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q3 2017, worth a combined $288K — down 55% from $646K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ETRM and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $54.6K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $66K sold.
- 14 institutional investors held EnteroMedics Inc. (ETRM) as of Q3 2017, down from 16 in Q2 2017.
- Funds reported $288K of EnteroMedics Inc. stock for Q3 2017, down 55% quarter-over-quarter.
- 4 funds opened new EnteroMedics Inc. positions in Q3 2017 and 6 closed out, a net change of -2 holders.
- The largest EnteroMedics Inc. buyer in Q3 2017 was D.E. Shaw & Co, an estimated $54.6K added.
- The largest EnteroMedics Inc. seller in Q3 2017 was Dimensional Fund Advisors, an estimated $66K sold.
Based on aggregated 13F filings for Q3 2017.